Loading your page…

Pharmaceutical group

Helsinn

31 medicines7 countries

A group of 4 companies with 31 medicines in 7 countries.

Its medicines

Group structure

4 companies in 2 countries

United States2

Ireland1

Helsinn Birex Pharmaceuticals LimitedAuthorisation holder · 24 medicines

Headquarters not stated1

Helsinn Birex Pharmac.ltdAuthorisation holder · listed in Italy

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

1–25 of 31

Medicine	Substance	Country	Status	Authorised
Akynzeo	Netupitant, Palonosetron	EU (EMA)	Authorised	2015
AKYNZEO235mg base/vial; 0.25mg base/vial · Powder	Fosnetupitant, Palonosetron	United States	Not marketed	2018
AKYNZEOCapsula rigida	Netupitant, Palonosetron	Italy	Authorised
AKYNZEO235mg base/20ml (eq 11.75mg base/ml); 0.25mg base/20ml (eq 0.0125mg base/ml) · Solution	Fosnetupitant, Palonosetron	United States	Marketed	2018
AKYNZEO300mg; 0.5mg base · Capsule	Netupitant, Palonosetron	United States	Marketed	2014
Akynzeo 235 mg / 0.25 mg concentraat voor oplossing voor infusieConcentraat voor oplossing voor infusie	Fosnetupitantchloridehydrochloride, Palonosetron	Netherlands	Authorised	2021
Akynzeo 235 mg / 0.25 mg poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie	Fosnetupitantchloridehydrochloride, Palonosetron	Netherlands	Authorised	2020
AKYNZEO 235 MG/0,25 MG POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN235 mg + 0,28 mg · Polvo para concentrado para solución para perfusión	Fosnetupitant, Palonosetron	Spain	Authorised	2020
AKYNZEO 300 MG/0,5 MG CAPSULAS DURAS100 mg + 0,5 mg · Cápsula dura	Netupitant, Palonosetron	Spain	Marketed	2015
Akynzeo 300 mg/0,5 mg suspensie voor oraal gebruik in sachetSuspensie voor oraal gebruik	Netupitant, Palonosetron	Netherlands	Authorised	2015
AKYNZEO 300 MG/0,5 MG SUSPENSION ORAL EN SOBRE300 mg + 0,56 mg · Suspensión oral	Netupitant, Palonosetron	Spain	Authorised	2026
Akynzeo 300 milligram / 500 microgram harde capsuleCapsule, hard	Netupitant, Palonosetron	Netherlands	Authorised	2015
ALOXI0.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons · Capsule	Palonosetron	United States	Not marketed	2008
ALOXI0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons · Injectable	Palonosetron	United States	Not marketed	2003
ALOXISoluzione iniettabile	Palonosetron	Italy	Authorised
Aloxi	Palonosetron	EU (EMA)	Authorised	2005
Aloxi 0,25 mg/5 ml, oplossing voor injectieOplossing voor injectie	Palonosetron	Netherlands	Authorised	2005
ALOXI 250 microgramos SOLUCION INYECTABLE50 µg · Solución inyectable	Palonosetron	Spain	Authorised	2005
Aloxi, 500 micrograms capsules, zachtCapsule, zacht	Palonosetron	Netherlands	Authorised	2010
AULINCompressa	Nimesulida	Italy	Authorised
Ledaga	Chlormethine	EU (EMA)	Authorised	2017
LEDAGAGel	Chlormethine	Italy	Authorised
LEDAGA 160 MICROGRAMOS/G GEL0,012 g · GEL	Chlormethine	Spain	Marketed	2017
LEDAGA 160 micrograms/g gelGel	Chlormethine	Netherlands	Authorised	2017
TRUSELTIQ100mg \| 25mg · Capsule	Infigratinib	United States	Not marketed	2021

Sources and licences

Country	Medicines	Current	Past	Companies
Netherlands	7	7	0	Companies All medicines
United States	7	7	0	Companies All medicines
Spain	5	5	0	Companies All medicines
European Union (EMA)	5	3	2	Companies All medicines
Italy	4	4	0	Companies All medicines
Romania	2	0	2	Companies All medicines
Saudi Arabia	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 16 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Ministerul Sănătății

Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

ALIMS

ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.

Licence: Serbian Open Data Licence (sodl)

Saudi Food and Drug Authority

Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.

Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only

Report an error or request removalCorrections from the company itself are welcome.

Helsinn

Group structure

United States2

Ireland1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Helsinn

Group structure

United States2

Ireland1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇺🇸United States2

🇮🇪Ireland1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Group structure

🇺🇸United States2

🇮🇪Ireland1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

United States2

Ireland1

United States2

Ireland1